These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15378053)

  • 1. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance.
    Blower SM; Chou T
    Nat Med; 2004 Oct; 10(10):1111-6. PubMed ID: 15378053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.
    Cohen T; Murray M
    Nat Med; 2004 Oct; 10(10):1117-21. PubMed ID: 15378056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug resistance in tuberculosis].
    Winje BA; Mannsåker T; Langeland N; Heldal E
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant tuberculosis can be controlled, says WHO.
    Brown P
    BMJ; 2000 Mar; 320(7238):821. PubMed ID: 10731157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
    Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
    Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H; Schaberg T; Gillissen A
    Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics.
    Basu S; Orenstein E; Galvani AP
    J Infect Dis; 2008 Nov; 198(10):1502-13. PubMed ID: 18816192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global incidence of multidrug-resistant tuberculosis.
    Zignol M; Hosseini MS; Wright A; Weezenbeek CL; Nunn P; Watt CJ; Williams BG; Dye C
    J Infect Dis; 2006 Aug; 194(4):479-85. PubMed ID: 16845631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of drug resistance in Mycobacterium tuberculosis in The Republic of Mariy El].
    Sevast'ianova EV; Petrova LV
    Probl Tuberk Bolezn Legk; 2008; (9):13-6. PubMed ID: 19065732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.